References
- Banerji A, Piccirillo JF, Thawley SE, et al. Chronic rhinosinusitis patients with polyps or polypoid mucosa have a greater burden of illness. Am J Rhinol. 2007;21(1):19–26.
- Rudmik L. Economics of chronic rhinosinusitis. Curr Allergy Asthma Rep. 2017;17(4):20.
- Smith KA, Orlandi RR, Rudmik L. Cost of adult chronic rhinosinusitis: a systematic review. Laryngoscope. 2015;125(7):1547–1556.
- Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(2 Suppl):S1–S39.
- Sedaghat AR, Kuan EC, Scadding GK. Epidemiology of chronic rhinosinusitis: prevalence and risk factors. J Allergy Clin Immunol Pract. 2022;10(6):1395–1403.
- Ference EH, Suh JD, Tan BK, et al. How often is sinus surgery performed for chronic rhinosinusitis with versus without nasal polyps? Am J Rhinol Allergy. 2018;32(1):34–39.
- Musy PY, Kountakis SE. Anatomic findings in patients undergoing revision endoscopic sinus surgery. Am J Otolaryngol. 2004;25(6):418–422.
- DeConde AS, Mace JC, Levy JM, et al. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2017;127(3):550–555.
- Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213–739.
- Scangas GA, Wu AW, Ting JY, et al. Cost utility analysis of dupilumab versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps. Laryngoscope. 2021;131(1):E26–e33.
- Rizzo JA, Rudmik L, Mallow PJ, et al. Budget impact analysis of bioabsorbable drug-eluting sinus implants following endoscopic sinus surgery. J Med Econ. 2016;19(9):829–835.
- Javanbakht M, Saleh H, Hemami MR, et al. A corticosteroid-eluting sinus implant following endoscopic sinus surgery for chronic rhinosinusitis: a UK-based cost-effectiveness analysis. Pharmacoecon Open. 2020;4(4):679–686.
- Santarelli GD, Han JK. Evaluation of the PROPEL® mini sinus implant for the treatment of frontal sinus disease. Expert Opin Drug Deliv. 2016;13(12):1789–1793.
- Hoffman V, Mortimer KM, Mulder K, et al. Real-world evidence analysis of the impact of steroid-eluting implants on healthcare resource use among chronic rhinosinusitis patients undergoing sinus surgery. Curr Med Res Opin. 2022;38(3):375–381.
- Schmalbach CE, Brereton J, Bowman C, et al. American academy of Otolaryngology-Head and neck surgery/foundation reg-ent registry: purpose, properties, and priorities. Otolaryngol Head Neck Surg. 2021;164(5):964–971.
- AAO-HNSF partners with OM1 to empower more measured and precise care and treatments for otolaryngology-head and Nneck surgery [Internet]. 2020; [28 May 2020, cited 30 August 2022]. Available from: https://bulletin.entnet.org/home/article/21247900/aao-hnsf-partners-with-om1-to-empower-more-measured-and-precise-care-and-treatments-for-otolaryngology-head-and-neck-surgery.
- Wang SV, He M, Jin Y, et al. A review of the performance of different methods for propensity score matched subgroup analyses and a summary of their application in peer-reviewed research studies. Pharmacoepidemiol Drug Saf. 2017;26(12):1507–1512.
- Wang SV, Jin Y, Fireman B, et al. Relative performance of propensity score matching strategies for subgroup analyses. Am J Epidemiol. 2018;187(8):1799–1807.
- Stein NR, Jafari A, DeConde AS. Revision rates and time to revision following endoscopic sinus surgery: a large database analysis. Laryngoscope. 2018;128(1):31–36.
- Smith KA, Orlandi RR, Oakley G, et al. Long-term revision rates for endoscopic sinus surgery. Int Forum Allergy Rhinol. 2019;9(4):402–408.